Physician profile
Gary E Leach
NPI 1225062797
$129,209.66
in general payments reported to CMS, 2019-2025
42 companies · $2,769 in 2025
The $2,769 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $28K · 2021: $22K · 2022: $26K · 2023: $19K · 2024: $12K · 2025: $2,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Food and Beverage: $5,587 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,250.00 |
| Food and Beverage | $5,586.62 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $75,742.99 | 2021-2025 | Interstim |
| Medtronic USA, INC. | $34,729.44 | 2019-2020 | |
| Astellas Pharma US INC | $10,724.00 | 2019-2023 | Xtandi |
| Abbvie INC. | $1,786.78 | 2019-2025 | |
| Coloplast Corp | $755.37 | 2019-2024 | Saffron |
| Teleflex LLC | $463.20 | 2021-2024 | Solesta |
| Boston Scientific Corporation | $436.74 | 2019-2021 | |
| Urogen Pharma, INC. | $366.11 | 2022-2023 | Jelmyto |
| Myovant Sciences INC. | $364.61 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $357.50 | 2021-2024 | Provenge |
| Axonics, INC. | $350.11 | 2021-2024 | Axonics, Bulkamid |
| Becton, Dickinson and Company | $334.03 | 2024 | Bard Urinary Drainage Bag |
| Allergan, INC. | $312.76 | 2019-2021 | |
| Pfizer INC. | $280.30 | 2019-2025 | |
| Janssen Biotech, INC. | $251.53 | 2019-2025 | Erleada |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $169.88 | 2022 | |
| Sumitomo Pharma America, INC. | $153.59 | 2023-2025 | Orgovyx, Gemtesa |
| Laborie Medical Technologies Corp. | $135.31 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Calyxo, INC. | $130.40 | 2025 | Cvac Aspiration System |
| C. R. Bard, INC. & Subsidiaries | $128.76 | 2023-2024 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $126.80 | 2021-2022 | |
| Telix Pharmaceuticals | $118.36 | 2024-2025 | Illuccix |
| Dornier Medtech America, INC | $102.06 | 2025 | Dornier Medtech |
| Urovant Sciences INC | $92.17 | 2022 | |
| Profound Medical Corp. | $88.19 | 2023 | Tulsa-Pro |
| Ferring Pharmaceuticals INC. | $84.86 | 2019-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $75.26 | 2022-2025 | Welireg, Keytruda |
| Blue Earth Diagnostics | $73.32 | 2022-2025 | Posluma |
| Neotract INC. | $65.95 | 2019-2020 | |
| Immunitybio, INC. | $64.89 | 2025 | |
| Abc Home Medical Supply, INC. | $54.19 | 2023-2025 | |
| Astellas Pharma Global Development | $44.03 | 2019 | |
| Contura, INC. | $41.50 | 2020 | |
| Myriad Genetic Laboratories, INC. | $32.45 | 2021-2023 | Prolaris |
| Hollister Incorporated | $29.14 | 2019-2024 | Vapro |
| 180 Medical, INC. | $28.39 | 2024 | |
| Ethicon US, LLC | $25.78 | 2021 | |
| Verity Pharmaceuticals INC. | $19.45 | 2022 | |
| Progenics Pharmaceuticals, INC. | $19.10 | 2024 | |
| Dentsply Ih INC. | $18.05 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $16.23 | 2023 | Lynparza |
| Antares Pharma, INC. | $16.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Leach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.